Elizabeth A. Harrington

Also affiliated with Columbia University Irving Medical Center, AstraZeneca (Singapore)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study”.

Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study

Neurotherapeutics(2022)10.1007/s13311-022-01237-4

N/A

4.7DataRank · unranked

168 citations

Joanne Wuu, Peter M Andersen, Robert C. Bucelli, Jinsy Andrews, Markus Otto +17 more

1-13C-propionate breath testing as a surrogate endpoint to assess efficacy of liver-directed therapies in methylmalonic acidemia (MMA)

Genetics in Medicine(2021)10.1038/s41436-021-01143-8

N/A

0.688DataRank · unranked

16 citations

Alexandra Pass, Elizabeth A. Harrington, Jennifer L. Sloan, Jack Gagné, Samantha McCoy +16 more

Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series

The Lancet(2025)10.1016/s0140-6736(25)00513-6

N/A

0.538DataRank · unranked

35 citations

Matthew B. Harms, Vladislav A. Korobeynikov, Olivia M. Rifai, Benjamin N. Hoover, Elizabeth A. Harrington +30 more

Body mass index is lower in asymptomatic C9orf72 expansion carriers but not in SOD1 pathogenic variant carriers compared to gene negatives

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration(2024)10.1080/21678421.2024.2396831

N/A

0.104DataRank · unranked

1 citations

Mark A. Garret, Joanne Wuu, Elizabeth A. Harrington, James D. Berry, Timothy M. Miller +4 more

Clinical testing panels for ALS: global distribution, consistency, and challenges

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration(2023)10.1080/21678421.2023.2173015

N/A

0DataRank · unranked

17 citations

Ahmad Al Nasser, Marwa Elnagheeb, Jennifer A. Fifita, Lyndal Henden, Ingrid M. Keseler +33 more

Serial monitoring of genomic alterations in circulating tumor cells of ER‐positive/HER2‐negative advanced breast cancer: feasibility of precision oncology biomarker detection

Molecular Oncology(2021)10.1002/1878-0261.13150

N/A

0DataRank · unranked

21 citations

Emily M. Dolce, Elizabeth P. Darga, Kevin Hu, Chia‐Jen Liu, Jackie Pierce +27 more

Sex differences in cardiac mitochondrial respiration and reactive oxygen species production may predispose Scn1a mice to cardiac arrhythmias and Sudden Unexpected Death in Epilepsy

Journal of Molecular and Cellular Cardiology Plus(2024)10.1016/j.jmccpl.2024.100090

N/A

0DataRank · unranked

1 citations

Emily Davis Alexander, Allison A. Franklin, Elizabeth A. Harrington, Farah Al-Ghzawi, Chad R. Frasier +1 more